Peginterferon and ribavirin treatment for hepatitis C virus infection

被引：49
|
作者：
Tsubota, Akihito [1 ]
Fujise, Kiyotaka [1 ]
Namiki, Yoshihisa [1 ]
Tada, Norio [1 ]
机构：
[1] Jikei Univ, Sch Med, Inst Clin Med & Res, Chiba 2778567, Japan
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2011年 / 17卷 / 04期
关键词：
Pegylated interferon alpha; Ribavirin; Chronic hepatitis C virus infection; Difficult-to-treat patient; Individualized treatment; Response-guided therapy; Specifically targeted antiviral therapy for hepatitis C virus; ALPHA-2B PLUS RIBAVIRIN; SUSTAINED VIROLOGICAL RESPONSE; PEGYLATED INTERFERON-ALPHA; CHRONIC HCV INFECTION; RANDOMIZED-TRIAL; HEPATOCELLULAR-CARCINOMA; NAIVE PATIENTS; COMBINATION THERAPY; GENOTYPE-1; PATIENTS; FUSION PROTEIN;
D O I：
10.3748/wjg.v17.i4.419
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Pegylated interferon alpha (IFN alpha) in combination with ribavirin is currently recommended as a standard-of-care treatment for chronic hepatitis C virus (HCV) infection. This combination therapy has drastically improved the rate of sustained virological response, specifically in difficult-to-treat patients. Recently, individualized treatment, such as response-guided therapy, is being developed based on host-, HCV- and treatment-related factors. Furthermore, modified regimens with currently available medications, novel modified IFN alpha and ribavirin or combinations with specifically targeted antiviral therapy for HCV agents, are currently being investigated. The purpose of this review is to address some issues and epoch-making topics in the treatment of chronic HCV infection, and to discuss more optimal and highly individualized therapeutic strategies for HCV-infected patients.
引用
收藏
页码：419 / 432
页数：14
相关论文
共 50 条
  • [1] Peginterferon and ribavirin treatment for hepatitis C virus infection
    Akihito Tsubota
    Kiyotaka Fujise
    Yoshihisa Namiki
    Norio Tada
    World Journal of Gastroenterology, 2011, 17 (04) : 419 - 432
  • [2] Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection
    Roulot, D.
    Bourcier, V.
    Grando, V.
    Deny, P.
    Baazia, Y.
    Fontaine, H.
    Bailly, F.
    Castera, L.
    De Ledinghen, V.
    Marcellin, P.
    Poupon, R.
    Bourliere, M.
    Zarski, J. P.
    Roudot-Thoraval, F.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (07) : 460 - 467
  • [3] SAFETY OF THE COMBINED TREATMENT OF CHRONIC HEPATITIS VIRUS C WITH RIBAVIRIN AND PEGINTERFERON ALPHA
    Neus, Sunyer Esquerra
    Isabel, De la Paz Castizares
    Sanchez Blanca, Martinez
    Maria Teresa, Butina Agusti
    ATENCION FARMACEUTICA, 2012, 14 (06): : 453 - 456
  • [4] Quasispecies of hepatitis C virus genotype 1 and treatment outcome with Peginterferon and Ribavirin
    Gomes Jardim, Ana Carolina
    Tomonari Yamasaki, Lilian Hiromi
    Lopo de Queiroz, Artur Trancoso
    Bittar, Cintia
    Rebello Pinho, Joao Renato
    Aparecida Carareto, Claudia Marcia
    Rahal, Paula
    Guedes de Carvalho Mello, Isabel Maria Vicente
    INFECTION GENETICS AND EVOLUTION, 2009, 9 (04) : 689 - 698
  • [5] Peginterferon and ribavirin for hepatitis C
    Ben Salem, Chaker
    Hmouda, Houssem
    Bouraoui, Kamel
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (12): : 1270 - 1270
  • [6] SHORTENED PEGINTERFERON AND RIBAVIRIN TREATMENT FOR CHRONIC HEPATITIS C
    Hartwell, Debbie
    Jones, Jeremy
    Baxter, Louise
    Shepherd, Jonathan
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (04) : 398 - 406
  • [7] Risk Factors for Infection During Treatment with Peginterferon alfa and Ribavirin for Chronic Hepatitis C
    Roomer, Robert
    Hansen, Bettina E.
    Janssen, Harry L. A.
    de Knegt, Robert J.
    HEPATOLOGY, 2010, 52 (04) : 1225 - 1231
  • [8] Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha
    Shiffman, Mitchell L.
    Salvatore, Jennifer
    Hubbard, Sarah
    Price, Angie
    Sterling, Richard K.
    Stravitz, R. Todd
    Luketic, Velituir A.
    Sanyal, Arun J.
    HEPATOLOGY, 2007, 46 (02) : 371 - 379
  • [9] Pegylated interferon and ribavirin treatment for hepatitis C virus infection
    Palumbo, Emilio
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2011, 2 (01) : 39 - 45
  • [10] Mycobacterium abscessus pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirin
    Soza, Alejandro
    Labbe, Pilar
    Arrese, Marco
    Riquelme, Arnoldo
    Barrera, Francisco
    Benitez, Carlos
    Huete, Alvaro
    Elvira Balcells, M.
    Labarca, Jaime
    ANNALS OF HEPATOLOGY, 2015, 14 (01) : 132 - 136
12345